ACADIA Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.

About ACAD

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. 

CEO
Catherine Owen Adams
CEOCatherine Owen Adams
Employees
654
Employees654
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1993
Founded1993
Employees
654
Employees654

ACAD Key Statistics

Market cap
4.54B
Market cap4.54B
Price-Earnings ratio
17.02
Price-Earnings ratio17.02
Dividend yield
Dividend yield
Average volume
1.21M
Average volume1.21M
High today
$26.86
High today$26.86
Low today
$26.35
Low today$26.35
Open price
$26.52
Open price$26.52
Volume
951.83K
Volume951.83K
52 Week high
$28.35
52 Week high$28.35
52 Week low
$13.40
52 Week low$13.40

Stock Snapshot

ACADIA Pharmaceuticals(ACAD) stock is priced at $26.83, giving the company a market capitalization of 4.54B. It carries a P/E multiple of 17.02.

As of 2026-01-15, ACADIA Pharmaceuticals(ACAD) stock has fluctuated between $26.35 and $26.86. The current price stands at $26.83, placing the stock +1.8% above today's low and -0.1% off the high.

The ACADIA Pharmaceuticals(ACAD)'s current trading volume is 951.83K, compared to an average daily volume of 1.21M.

During the past year, ACADIA Pharmaceuticals(ACAD) stock moved between $13.40 at its lowest and $28.35 at its peak.

During the past year, ACADIA Pharmaceuticals(ACAD) stock moved between $13.40 at its lowest and $28.35 at its peak.

ACAD News

Simply Wall St 19h
Is It Time To Reconsider ACADIA Pharmaceuticals After Recent Share Price Weakness

If you are wondering whether ACADIA Pharmaceuticals' current share price still offers value after recent moves, this article walks through the numbers so you ca...

Is It Time To Reconsider ACADIA Pharmaceuticals After Recent Share Price Weakness
TipRanks 1d
ACADIA Pharmaceuticals Clarifies Form 8-K Disclosure Treatment

Claim 70% Off TipRanks Premium ACADIA Pharmaceuticals ( (ACAD) ) has issued an announcement. In a recent regulatory filing, ACADIA Pharmaceuticals specified t...

TipRanks 1d
Acadia Pharmaceuticals sees 2025 net sales to exceed $1B, consensus $1.08B

In a regulatory filing, Acadia Pharmaceuticals (ACAD) disclosed that on January 13, the company presented at the J.P. Morgan Healthcare Conference announcing, a...

Analyst ratings

65%

of 20 ratings
Buy
65%
Hold
30%
Sell
5%

People also own

Based on the portfolios of people who own ACAD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .